FDA warning letters rarely mention AI, retrospective analysis finds - Bioengineer.org

A review of FDA warning letters found that regulators rarely flag AI as a concern in medical device reviews. This suggests the FDA may not be fully scrutinizing AI risks in healthcare yet, which matters for patient safety.